| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 0.27% |
| NAV | ₹9.82 (07 Aug 2020) |
|---|---|
| Fund Started | 29 Jun 2018 |
| Fund Size | ₹588 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| HDFC Life Insurance Co Ltd. | Financial | Equity | 5.4% |
| Avenue Supermarts Ltd. | Services | Equity | 4.7% |
| SBI Life Insurance Company Ltd. | Financial | Equity | 4.2% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 3.9% |
| Dabur India Ltd. | FMCG | Equity | 3.5% |
| Godrej Consumer Products Ltd. | FMCG | Equity | 3.5% |
| ICICI Lombard General Insurance Company Ltd. | Financial | Equity | 3.4% |
| Lupin Ltd. | Healthcare | Equity | 3.0% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 2.9% |
| Pidilite Industries Ltd. | Chemicals | Equity | 2.8% |
UTI Nifty Next 50 Index Fund Direct Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 29 Jun 2018. Kaushik Basu, Sharwan Kumar Goyal is the Current Fund Manager of UTI Nifty Next 50 Index Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹588 Cr and the Latest NAV as of 07 Aug 2020 is ₹9.82.
The UTI Nifty Next 50 Index Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000.
The investment objective of the scheme is to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.However there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.